{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:22:53Z","timestamp":1772839373773,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) are prevalent among women. While low-level laser therapy (LLLT) has been employed for wound healing, no studies have explored its effectiveness in treating GSM and SUI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between September 2022 and August 2023, all women received LLLT for GSM and SUI at the gynecologic outpatient clinic of a hospital were retrospectively reviewed. The treatment was administered once a week for 8 weeks. Vaginal Health Index (VHI) and pre- and post-treatment questionnaires were utilized to assess lower urinary tract symptoms (LUTS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 41 women were enrolled, including 24 (59%) with SUI and 22 (52%) with GSM (5 women reported both conditions). Significant improvements were observed in all VHI items for both groups. Total scores for ICIQ-SF (International Consultation on Incontinence Questionnaire-Short Form), UDI-6 (Urogenital Distress Inventory-6), IIQ-7(Incontinence Impact Questionnaire-7), USS (Urgency Severity Scale), and OABSS (Overactive Bladder Symptom Score) demonstrated significant enhancements in all women and specifically in the GSM group. In the SUI group, USS and OABSS significantly improved, with more domains in KHQ (King\u2019s Health Questionnaire) showing improvement compared to the GSM group. In the GSM group, lubrication, pain, and the total score of FSFI (Female Sexual Function Index) improved significantly, while no significant enhancement in sexual function was observed in the SUI group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This pilot study indicates that LLLT is a safe, cost-effective, and straightforward treatment for alleviating GSM and SUI symptoms. Women with GSM experienced improvements in LUTS and sexual function, while women with SUI demonstrated improvements in urinary urgency and LUTS-related quality of life. This study represents the first application of LLLT in gynecology.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1574646","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:10:58Z","timestamp":1747973458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The efficacy of low-level laser therapy in alleviating genitourinary syndrome of menopause and stress urinary incontinence: the pilot study"],"prefix":"10.3389","volume":"12","author":[{"given":"Pei-Chi","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Hsiung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hau","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Shing","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/GME.0000000000001728","article-title":"The genitourinary syndrome of menopause.","volume":"28","author":"Phillips","year":"2021","journal-title":"Menopause."},{"key":"B2","doi-asserted-by":"publisher","first-page":"779398","DOI":"10.3389\/frph.2021.779398","article-title":"Genitourinary syndrome of menopause: Epidemiology, physiopathology, clinical manifestation and diagnostic.","volume":"3","author":"Sarmento","year":"2021","journal-title":"Front Reprod Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol Urodyn."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1111\/jog.15742","article-title":"Menopause and stress urinary incontinence: The risk factors of stress urinary incontinence in perimenopausal and postmenopausal women.","volume":"49","author":"Huang","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.maturitas.2017.01.012","article-title":"Laser therapy for the restoration of vaginal function.","volume":"99","author":"Gambacciani","year":"2017","journal-title":"Maturitas."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1038\/s41598-022-06601-0","article-title":"Changes in sexual function and vaginal topography using transperineal ultrasound after vaginal laser treatment for women with stress urinary incontinence.","volume":"12","author":"Long","year":"2022","journal-title":"Sci Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.17219\/acem\/37263","article-title":"The use of low-level energy laser radiation in basic and clinical research.","volume":"23","author":"Rola","year":"2014","journal-title":"Adv Clin Exp Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00192-015-2932-1","article-title":"An International urogynecological association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP).","volume":"27","author":"Haylen","year":"2016","journal-title":"Int Urogynecol J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/s0002-9378(96)70243-0","article-title":"The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.","volume":"175","author":"Bump","year":"1996","journal-title":"Am J Obstet Gynecol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/13697137.2019.1600499","article-title":"Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy.","volume":"22","author":"Palacios","year":"2019","journal-title":"Climacteric."},{"key":"B11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/nau.20546","article-title":"The Chinese version of ICIQ: A useful tool in clinical practice and research on urinary incontinence.","volume":"27","author":"Huang","year":"2008","journal-title":"Neurourol Urodyn."},{"key":"B12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/nau.1930140206","article-title":"Short forms to assess life quality and symptom distress for urinary incontinence in women: The Incontinence impact questionnaire and the urogenital distress inventory. continence program for women research group.","volume":"14","author":"Uebersax","year":"1995","journal-title":"Neurourol Urodyn."},{"key":"B13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","article-title":"Symptom assessment tool for overactive bladder syndrome\u2013overactive bladder symptom score.","volume":"68","author":"Homma","year":"2006","journal-title":"Urology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/01.ju.0000165461.38088.7b","article-title":"A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials.","volume":"174","author":"Nixon","year":"2005","journal-title":"J Urol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","article-title":"A new questionnaire to assess the quality of life of urinary incontinent women.","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br J Obstet Gynaecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejon.2015.06.007","article-title":"Sexual function in cervical cancer patients: Psychometric properties and performance of a Chinese version of the Female Sexual Function Index.","volume":"20","author":"Liu","year":"2016","journal-title":"Eur J Oncol Nurs."},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5114\/pq.2021.102549","article-title":"Effect of low level laser on pelvic floor muscles and fascia in cases of stress urinary incontinence: A randomized controlled trial.","volume":"29","author":"Mousa","year":"2021","journal-title":"Physiother Quart."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1007\/s00192-022-05153-1","article-title":"Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: A phase III study.","volume":"33","author":"Hwang","year":"2022","journal-title":"Int Urogynecol J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jsxm.2017.09.004","article-title":"Low-level laser therapy for the treatment of provoked vestibulodynia-A randomized.","volume":"14","author":"Lev-Sagie","year":"2017","journal-title":"Placebo-Controlled Pilot Trial. J Sex Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejogrb.2022.08.012","article-title":"Fractional CO2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review.","volume":"277","author":"D\u2019Oria","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.6118\/jmm.22017","article-title":"Vaginal laser therapy for stress urinary incontinence: A systematic review of prospective randomized clinical trials.","volume":"28","author":"Ranjbar","year":"2022","journal-title":"J Menopausal Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/asj\/sjab025","article-title":"Photobiomodulation: The clinical applications of low-level light therapy.","volume":"41","author":"Glass","year":"2021","journal-title":"Aesthet Surg J."},{"key":"B23","first-page":"621","article-title":"The effect of laser beams on the growth of hair in mice.","volume":"9","author":"Mester","year":"1968","journal-title":"Radiobiol Radiother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1423-0127-16-4","article-title":"Molecular mechanisms of cell proliferation induced by low power laser irradiation.","volume":"16","author":"Gao","year":"2009","journal-title":"J Biomed Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/lsm.10126","article-title":"Influence of low level laser therapy on wound healing and its biological action upon myofibroblasts.","volume":"32","author":"Medrado","year":"2003","journal-title":"Lasers Surg Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00520-016-3152-z","article-title":"Low level laser therapy\/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 1: Mechanisms of action, dosimetric, and safety considerations.","volume":"24","author":"Zecha","year":"2016","journal-title":"Support Care Cancer."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1007\/s10103-022-03587-z","article-title":"Response of osteoblastic cells to low-level laser treatment: A systematic review.","volume":"37","author":"Garz\u00f3n","year":"2022","journal-title":"Lasers Med Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1089\/pho.2006.24.158","article-title":"Low-level laser therapy in acute pain: A systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials.","volume":"24","author":"Bjordal","year":"2006","journal-title":"Photomed Laser Surg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jama.2021.14892","article-title":"Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: A randomized clinical trial.","volume":"326","author":"Li","year":"2021","journal-title":"JAMA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5213\/inj.1836212.106","article-title":"Urodynamic and bladder diary factors predict overactive bladder-wet in women: A comparison with overactive bladder-dry.","volume":"23","author":"Hsiao","year":"2019","journal-title":"Int Neurourol J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00345-021-03865-5","article-title":"Prevalence and predictors of nocturnal polyuria in females with overactive bladder syndrome.","volume":"40","author":"Wu","year":"2022","journal-title":"World J Urol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1574646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:10:58Z","timestamp":1747973458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1574646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":31,"alternative-id":["10.3389\/fmed.2025.1574646"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1574646","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"article-number":"1574646"}}